<DOC>
	<DOC>NCT00054964</DOC>
	<brief_summary>This study was designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.</brief_summary>
	<brief_title>Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique</brief_title>
	<detailed_description>This was a single-center, randomized, open-label, active-controlled, 2-period, 2-sequence, single dose-dose, crossover comparison of the ability of Albuterol BOI-HFA to produce bronchodilation relative to that produced by to albuterol MDI-HFA in at least 12 asthmatics with poor inhaler coordinating ability.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Asthma diagnosed ≥6 months prior and stable for 4 weeks prior to screening Poor inhaler coordination as assessed at screening Reversible bronchoconstriction (≥ 12% increase in FEV1) Albuterol allergy Investigational drug within 30 days Injected corticosteroid within 6 weeks Requires betablockers, MAO inhibitors, tricyclic antidepressants, longacting betablockers, steroids other than those inhaled Other criterial apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>